Anasarca Diagnosis: A Comprehensive Guide for Healthcare Professionals

Introduction to Anasarca

Anasarca is a severe form of generalized edema characterized by widespread swelling of tissues throughout the body. Unlike peripheral edema, which is localized, anasarca involves massive fluid accumulation in the interstitial space. This condition is not a disease itself but rather a clinical sign of an underlying medical issue, often stemming from imbalances in fluid regulation due to cardiac, renal, hepatic, or lymphatic system disorders. Understanding the complexities of anasarca is crucial for healthcare professionals to ensure timely and effective patient care.

The development of anasarca occurs when capillary filtration surpasses the lymphatic system’s capacity to remove fluid, leading to fluid buildup in the interstitial spaces. This imbalance can be triggered by several factors, including increased intravascular hydrostatic pressure, heightened endothelial barrier permeability, decreased capillary oncotic pressure, or changes in oncotic pressure due to low protein states. Recognizing anasarca and accurately diagnosing its underlying cause are paramount for initiating appropriate treatment strategies and improving patient outcomes. Early and precise Anasarca Diagnosis is the cornerstone of effective management and can significantly impact patient prognosis.

Unpacking the Etiology of Anasarca

The etiology of anasarca is diverse, reflecting the numerous systemic conditions that can disrupt fluid homeostasis. A thorough understanding of these potential causes is essential for accurate anasarca diagnosis and targeted treatment. Several key pathologies can precipitate this condition:

Renal Failure: Kidney dysfunction, particularly conditions like glomerulonephritis, can lead to significant protein loss, resulting in decreased capillary oncotic pressure. This reduction allows fluid to leak from blood vessels into interstitial tissues, causing generalized edema. Furthermore, renal diseases can impair the body’s ability to regulate salt and water balance, contributing to fluid retention and exacerbating edema.
Liver Diseases: The liver’s role in albumin production is critical for maintaining capillary oncotic pressure. Conditions such as cirrhosis that compromise liver function can lead to hypoalbuminemia. Reduced albumin levels decrease oncotic pressure, facilitating fluid movement from blood vessels into interstitial spaces and causing anasarca.
Malnutrition: Severe protein or caloric deficiencies can also result in hypoalbuminemia. Inadequate protein intake reduces the body’s capacity to synthesize albumin, leading to decreased oncotic pressure and subsequent fluid retention, potentially manifesting as anasarca.
Endocrinopathies: Certain endocrine disorders, such as hypothyroidism, can contribute to fluid retention. Hypothyroidism, in particular, is associated with generalized nonpitting edema, partly due to the accumulation of glycosaminoglycans in tissues, which attract water.
Medications: A range of medications can induce fluid retention as a side effect. Corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and calcium channel blockers are among the drugs known to potentially cause significant fluid retention, contributing to the development of anasarca in susceptible individuals.

Understanding these varied etiologies is crucial for a comprehensive anasarca diagnosis, guiding clinicians toward appropriate investigations and management strategies tailored to the underlying cause.

Epidemiology of Anasarca

Precise epidemiological data on anasarca are limited, as it is often reported as a symptom of underlying conditions rather than a primary diagnosis. However, understanding the context of edema prevalence can provide some perspective. Peripheral edema, a less severe form of fluid accumulation, is estimated to affect approximately 20% of adults over the age of 50. This figure highlights the significant prevalence of fluid balance issues in the adult population, although anasarca represents a more extreme and less frequent manifestation.

One study focusing on postoperative patients undergoing major abdominal surgery reported an anasarca incidence of around 29.87%. This specific context underscores that certain medical interventions and patient populations may be at higher risk for developing anasarca. Further research is needed to fully elucidate the epidemiology of anasarca across different populations and underlying conditions. Nevertheless, the available data emphasize the clinical relevance of anasarca diagnosis and management, particularly in patients with predisposing conditions or undergoing major medical procedures.

Pathophysiology Behind Anasarca

The pathophysiology of anasarca is rooted in disruptions to the Starling forces, which govern fluid exchange between blood vessels and the interstitial space. Understanding these mechanisms is crucial for grasping how anasarca develops and for effective anasarca diagnosis. The key pathophysiological factors include:

Increased Capillary Hydrostatic Pressure: Elevated pressure within blood capillaries forces more fluid out into the interstitial space. Conditions such as heart failure, kidney disease, early cirrhosis, and venous obstruction (e.g., deep vein thrombosis, hepatic venous congestion) can increase capillary hydrostatic pressure, leading to fluid extravasation and edema. Certain medications, like amlodipine, can also contribute to this mechanism.
Increased Capillary Permeability: Damage or dysfunction of the capillary endothelial barrier can increase its permeability, allowing more fluid and proteins to leak into the interstitium. Conditions such as burns, trauma, sepsis, allergic reactions, and malignant ascites can compromise capillary integrity, promoting fluid leakage and edema formation.
Decreased Plasma Oncotic Pressure: Oncotic pressure, primarily maintained by plasma proteins, particularly albumin, draws fluid back into capillaries. Hypoalbuminemia, resulting from conditions like nephrotic syndrome, liver disease, and malnutrition, reduces plasma oncotic pressure. This decrease diminishes the reabsorption of interstitial fluid into capillaries, leading to fluid accumulation and anasarca.
Lymphatic Obstruction: The lymphatic system plays a critical role in draining excess interstitial fluid. Obstruction of lymphatic vessels, due to malignancy or lymphatic dissection, impairs fluid removal from the interstitial space. This blockage leads to fluid buildup and contributes to the development of edema, although lymphatic obstruction is less commonly a primary cause of generalized anasarca compared to the other mechanisms.

These pathophysiological mechanisms often interact, leading to a complex interplay of factors driving fluid accumulation in anasarca. When fluid shifts from the vascular space to the interstitium, it reduces plasma volume, triggering renal retention of sodium and water. This renal response further exacerbates interstitial fluid retention, creating a vicious cycle that worsens edema. While some of the retained fluid remains in the intravascular compartment, the altered capillary hemodynamics predominantly drive the excess fluid into the interstitium, eventually becoming clinically apparent as anasarca.

History and Physical Examination for Anasarca Diagnosis

Clinical Presentation of Anasarca

Anasarca presents with extensive and generalized fluid accumulation across various body tissues. This widespread edema can affect multiple areas, including subcutaneous tissues, lungs, abdomen, and extremities, making clinical recognition relatively straightforward in severe cases. The clinical presentation of anasarca encompasses several key signs and symptoms:

Significant Generalized Swelling: This is the hallmark of anasarca, affecting the face, limbs, abdomen, dependent areas (such as ankles and sacrum), and the genital area. The swelling is typically pitting, meaning that pressing on the swollen area leaves a temporary indentation.
Restricted Movement: Swelling in extremities can limit range of motion and cause discomfort, impacting mobility and daily activities.
Increased Body Weight: Fluid retention leads to a noticeable increase in body weight over a short period, reflecting the excess fluid volume.
Pulmonary Edema: Fluid accumulation in the lungs can cause shortness of breath, particularly when lying down (orthopnea), cough, and chest pain. Pulmonary edema is a serious complication requiring prompt attention.
Ascites and Abdominal Distension: Fluid accumulation in the peritoneal cavity (ascites) causes abdominal swelling and distension, often associated with a feeling of fullness and discomfort.
Oliguria or Anuria: Reduced urine output (oliguria) or absence of urine output (anuria) can indicate renal dysfunction or significant fluid retention, further contributing to edema.
Fatigue: Systemic fluid overload and underlying conditions can lead to generalized fatigue and weakness.
Dermatological Changes: The skin overlying swollen areas may exhibit various changes, including erythema (redness), stretching, shiny appearance, weeping (fluid leakage), and tautness. In chronic edema, hemosiderin deposits and venous ulcers may develop. Hypothyroid-associated myxedema can present with nonpitting edema and skin thickening.

Comprehensive Patient History

A detailed patient history is crucial for anasarca diagnosis, helping to identify potential underlying causes and guiding further evaluation. The history should encompass:

Medical, Surgical, and Medication History: Reviewing past medical conditions, surgical procedures, and current medications is essential. Certain medications (e.g., amlodipine, NSAIDs) and postsurgical complications can directly contribute to edema. Pre-existing comorbidities, such as heart failure, renal disease, or hepatic disease, are significant risk factors for anasarca.
History of Anasarca Symptoms: Inquire about the onset, duration, and progression of edema. Determine the affected areas, presence of associated pain or discomfort, and positional effects on edema (e.g., whether elevation improves swelling).
Associated Symptoms: Explore other symptoms, such as dyspnea, chest pain, abdominal discomfort, and changes in urine output. Note any recent onset or exacerbation of systemic conditions known to cause fluid accumulation.

A thorough symptom history can provide valuable clues to the underlying etiology. For instance, edema that improves with elevation may suggest venous insufficiency, while edema unresponsive to positional changes might point towards decreased plasma oncotic pressure, as seen in nephrotic syndrome or malabsorption. Careful history taking is vital for narrowing down the differential anasarca diagnosis.

Physical Examination Findings

Physical examination is paramount in anasarca diagnosis. Vital signs may reveal abnormalities secondary to fluid overload, such as tachycardia, tachypnea, and decreased oxygen saturation. The physical exam should focus on:

Edema Pattern Assessment: Distinguish between peripheral and generalized edema. Characterize the edema as pitting or nonpitting. Pitting edema, common in dependent areas, indicates excess interstitial water that shifts with pressure. Nonpitting edema is more suggestive of lymphatic obstruction or myxedema associated with hypothyroidism.
Evaluation for Underlying Etiology Clues: Ascites suggests possible hepatic disease. Signs of volume overload, such as jugular venous distension and abnormal heart sounds (e.g., S3 gallop), may indicate cardiovascular-associated anasarca.

Common physical exam findings in anasarca include:

Generalized pitting edema affecting multiple body regions.
Increased jugular venous pressure (JVP) in cases of heart failure.
Ascites, detected by abdominal distension, shifting dullness on percussion, or fluid wave.
Pulmonary rales or crackles on auscultation, indicative of pulmonary edema.
Skin changes as described in the clinical presentation.

Evaluation and Diagnostic Studies for Anasarca

Evaluation for anasarca primarily aims to identify the underlying cause and exclude other conditions in the differential diagnosis. Given the involvement of multiple organ systems (urinary, cardiovascular, respiratory), a collaborative approach involving specialists from cardiology, nephrology, gastroenterology, and oncology may be necessary. The diagnostic process typically includes laboratory and imaging studies to pinpoint the etiology of anasarca.

Laboratory Studies

Laboratory tests play a crucial role in anasarca diagnosis by assessing organ function and identifying potential causes. Key laboratory investigations include:

Complete Blood Count (CBC): Evaluates red blood cell count, white blood cell count, and platelet count. While not directly diagnostic of anasarca, it can provide insights into underlying systemic conditions. In some cases, like TAFRO syndrome, thrombocytopenia may be present.
Serum Electrolytes, Blood Urea Nitrogen (BUN), and Creatinine: These tests assess renal function and electrolyte balance. Elevated BUN and creatinine indicate kidney dysfunction, a common cause of anasarca. Electrolyte imbalances, such as hyponatremia, can also be associated with fluid retention.
Liver Function Tests (LFTs): Alanine transaminase (ALT), aspartate transaminase (AST), alkaline phosphatase, bilirubin, and albumin levels evaluate liver function. Low albumin levels (hypoalbuminemia) are a critical indicator of liver disease or nephrotic syndrome as a cause of anasarca.
Urinalysis: Assesses urine protein, blood, and other abnormalities. Proteinuria, especially in the nephrotic range (greater than 3.5 grams of protein per day), strongly suggests nephrotic syndrome as the underlying cause of anasarca. Urine protein-to-creatinine ratio can quantify proteinuria efficiently.
Thyroid Function Tests: Thyroid-stimulating hormone (TSH) and free thyroxine (Free T4) levels are measured to assess thyroid function. Hypothyroidism can cause nonpitting edema and should be considered in the differential diagnosis of anasarca.
Brain Natriuretic Peptide (BNP) or N-terminal pro-BNP (NT-proBNP): These biomarkers are elevated in heart failure. Elevated BNP or NT-proBNP levels support heart failure as the underlying cause of anasarca. However, it’s important to note that heart failure can occur with normal BNP levels, particularly in certain conditions like constrictive pericarditis.
Serum and Urine Protein Electrophoresis: May be indicated if amyloidosis is suspected as an underlying cause of nephrotic syndrome or heart failure.

Imaging Studies

Imaging studies provide visual assessments of organ systems and fluid accumulation, aiding in anasarca diagnosis:

Chest X-ray: Evaluates for cardiomegaly (enlarged heart) and pulmonary edema. Cardiomegaly can suggest heart failure, while pulmonary edema confirms fluid overload in the lungs. Chest X-rays are useful for assessing cardiac and pulmonary involvement in anasarca.
Echocardiogram: Provides detailed images of the heart’s structure and function. It can assess cardiac function, identify valve abnormalities, and detect pericardial effusion, helping to diagnose heart failure as a cause of anasarca.
Abdominal Ultrasound: Evaluates the liver, kidneys, and presence of ascites. It can detect liver cirrhosis, renal abnormalities, and quantify ascites, aiding in the diagnosis of liver and kidney-related causes of anasarca.
Computed Tomography (CT) Scan: May be used for more detailed evaluation of the abdomen and chest if ultrasound findings are inconclusive or to investigate for malignancy or lymphatic obstruction. CT scans can provide cross-sectional images to assess organomegaly, lymphadenopathy, and fluid collections.

Treatment and Management Strategies for Anasarca

The primary approach to anasarca treatment is to address the underlying medical condition causing fluid overload. Additionally, most patients with anasarca require diuretic therapy to manage systemic fluid retention. Prompt recognition and treatment of pulmonary edema, a potentially life-threatening complication of anasarca, are critical to prevent adverse outcomes and mortality.

Diuretic Therapy

Diuretics are the cornerstone of symptomatic treatment for anasarca, promoting fluid excretion and reducing edema. The choice of diuretic and treatment approach depends on the underlying cause and clinical presentation.

Loop Diuretics: Such as furosemide and bumetanide, are potent diuretics that inhibit sodium reabsorption in the loop of Henle in the kidneys. They are highly effective for rapid fluid removal, particularly in patients with heart failure, nephrotic syndrome, or primary sodium retention. In patients with pulmonary edema and generalized edema due to these conditions, loop diuretics are often the first-line treatment. American Heart Association (AHA) guidelines recommend prompt diuretic therapy for fluid-overloaded heart failure patients presenting with shortness of breath.
Thiazide Diuretics: Like hydrochlorothiazide, are less potent than loop diuretics and work by inhibiting sodium reabsorption in the distal convoluted tubule. They can be used in combination with loop diuretics or as monotherapy for milder cases of edema or for maintenance therapy.
Spironolactone: An aldosterone antagonist, is particularly useful in managing edema associated with cirrhosis. It blocks aldosterone’s effects, reducing sodium and water retention. Spironolactone can be used alone or in combination with loop diuretics for cirrhosis-related ascites and anasarca. For initial management of cirrhotic ascites, European Association for the Study of the Liver (EASL) guidelines suggest spironolactone as first-line therapy, while American Association for the Study of Liver Diseases (AASLD) guidelines recommend combination therapy with spironolactone and furosemide for faster natriuresis.

Diuretic therapy should be carefully monitored to avoid volume depletion, electrolyte imbalances (especially hypokalemia and hyponatremia), and renal dysfunction. In conditions like venous or lymphatic obstruction or malignant ascites, diuretic therapy alone may be less effective and could lead to volume depletion without significant edema reduction.

Nonpharmacologic Management

In addition to diuretics, nonpharmacologic measures are essential for managing anasarca:

Sodium and Fluid Restriction: Limiting sodium intake reduces sodium and water retention, complementing diuretic therapy. The International Ascites Club recommends a sodium intake of 2000 mg daily for patients with ascites. AHA guidelines advise sodium restriction based on the stage of heart failure. Fluid restriction, typically around 2 liters per day, is often recommended, with stricter limits for patients with hyponatremia or diuretic resistance.
Nutritional Support: Addressing underlying malnutrition and ensuring a balanced diet, particularly adequate protein intake, can help improve hypoalbuminemia and reduce edema.
Albumin Infusion: In some cases of severe hypoalbuminemia, intravenous albumin infusions may be used to increase plasma oncotic pressure and draw fluid back into the bloodstream. However, albumin infusions are generally considered adjunctive therapy and not a primary treatment for anasarca.
Treatment of Underlying Infection: If anasarca is secondary to an infection (e.g., sepsis), appropriate antimicrobial therapy is crucial.
Hemodialysis: In patients with kidney failure as the primary cause of anasarca, hemodialysis may be necessary to remove excess fluid and waste products.

Ancillary Therapies

Targeted therapies for specific areas affected by edema can provide symptomatic relief:

Mechanical Therapies for Lower Extremity Edema: Leg elevation and compression stockings are beneficial for lower extremity edema. Leg elevation promotes venous return and reduces hydrostatic pressure in the legs. Compression stockings providing 30 to 40 mm Hg pressure are often recommended, unless peripheral arterial disease is present.
Lymphatic Massage and Compression for Lymphedema: For lymphedema, lymphatic massage combined with compressive bandages can enhance lymphatic drainage. Compression stockings or pneumatic compression devices may be used for maintenance therapy. Diuretics are typically not effective for lymphedema.

Monitoring and Follow-up

Following initial management, close monitoring is essential. Diuretic dosages can be adjusted based on clinical response and urine sodium concentration. Monitoring urine sodium levels can help guide diuretic titration, aiming for urine sodium concentration to exceed urine potassium concentration, indicating effective natriuresis.

Differential Diagnosis of Anasarca

The differential diagnosis of anasarca includes a wide range of conditions that can cause generalized severe edema. Considering these alternatives is vital for accurate anasarca diagnosis and targeted management:

Heart Failure: Both systolic and diastolic heart failure can lead to fluid retention and anasarca due to increased capillary hydrostatic pressure and sodium retention.
Kidney Diseases: Glomerular diseases such as nephrotic syndrome, glomerulonephritis (e.g., IgA nephropathy), and other renal pathologies are major causes of anasarca due to protein loss and fluid retention.
Liver Cirrhosis: Advanced liver disease leading to hypoalbuminemia and portal hypertension is a significant cause of ascites and generalized edema.
Hypoproteinemia: Conditions causing severe protein loss, such as malnutrition or protein-losing enteropathies, can result in hypoalbuminemia and anasarca.
Hypothyroidism: Myxedema associated with hypothyroidism can cause nonpitting generalized edema.
Medication-Induced Edema: Certain medications, including calcium channel blockers (e.g., amlodipine) and NSAIDs, can induce fluid retention and edema.
Severe Allergic Reactions: Anaphylaxis and severe allergic reactions can cause increased capillary permeability and angioedema, sometimes manifesting as generalized edema.
Lymphedema: Although typically localized, severe lymphedema can be widespread and mimic generalized edema in some cases.
Pregnancy: Physiological changes in pregnancy can lead to edema, although severe anasarca is less common and warrants investigation for underlying preeclampsia or other complications.
Malignancies: Advanced stages of certain malignancies, particularly those causing lymphatic obstruction or hypoalbuminemia, can contribute to edema.
Amyloidosis: Systemic amyloidosis can affect the heart, kidneys, and liver, leading to heart failure, nephrotic syndrome, and liver dysfunction, all of which can cause anasarca.
Autoimmune Diseases: Juvenile dermatomyositis and other autoimmune conditions can present with anasarca.
Hematological Disorders: Rare hematological conditions like acute myeloid leukemia and TAFRO syndrome (Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis, Renal Insufficiency, and Organomegaly) are also in the differential.
Cellulitis and Sepsis: While typically causing localized edema, severe cellulitis or sepsis can lead to systemic inflammation and generalized edema due to increased capillary permeability.
Deep Vein Thrombosis (DVT): Usually causes unilateral leg edema, but bilateral DVT or extensive DVT can contribute to systemic fluid overload.

Prognosis of Anasarca

The prognosis for anasarca is largely dependent on the underlying cause and the timeliness and effectiveness of treatment. If the underlying etiologic factors are treatable, anasarca can be a reversible condition. For instance, anasarca caused by medications or infections generally has a favorable prognosis with drug cessation or appropriate antimicrobial therapy.

However, anasarca resulting from chronic and progressive conditions such as advanced heart failure, severe kidney disease, or end-stage liver failure carries a more guarded prognosis. In these cases, the severity and progression of the underlying disease significantly influence the overall prognosis. Anasarca in the context of advanced organ failure often indicates a poorer outlook, reflecting the severity of the primary illness.

Potential Complications of Anasarca

Anasarca can lead to a range of complications affecting various organ systems and overall patient well-being:

Organ Dysfunction: Fluid overload can impair organ function, including cardiac, renal, and respiratory systems.
Skin Ulcers and Infections: Edematous skin is more fragile and prone to breakdown, increasing the risk of skin ulcers, cellulitis, and other skin infections.
Reduced Mobility: Extensive swelling can severely limit mobility and physical function, impacting quality of life.
Nutritional Deficiencies: Underlying conditions causing anasarca, such as malnutrition or protein-losing enteropathies, can lead to nutritional deficits.
Weight Gain and Body Image Issues: Fluid retention causes significant weight gain and body image concerns for patients.
Impaired Wound Healing: Edema impairs tissue perfusion and oxygenation, hindering wound healing.
Deep Vein Thrombosis (DVT): Reduced mobility and altered hemodynamics in anasarca can increase the risk of DVT.
Respiratory Distress: Pulmonary edema is a severe complication of anasarca, leading to respiratory distress and potentially respiratory failure.
Pericardial Effusion and Tamponade: Fluid accumulation around the heart (pericardial effusion) can, in severe cases, lead to cardiac tamponade, a life-threatening condition.
Complications Related to Underlying Etiologies and Diuretic Treatment: Complications can also arise from the underlying diseases causing anasarca or from side effects of diuretic therapy, such as electrolyte imbalances and renal dysfunction.

Deterrence and Patient Education for Anasarca

Preventing anasarca and its complications relies heavily on early intervention and patient education. Since anasarca often manifests as a late symptom of poorly managed underlying conditions, proactive patient education is crucial. Key aspects of deterrence and patient education include:

Awareness of Risk Factors: Educate patients about chronic medical conditions that increase anasarca risk if poorly managed, such as heart failure, kidney disease, liver disease, and inflammatory disorders.
Early Warning Signs: Inform patients about early signs of anasarca, including swelling in legs, ankles, and face, and shortness of breath. Encourage them to seek prompt medical attention if these symptoms develop.
Lifestyle Modifications: Emphasize the importance of lifestyle changes for managing conditions contributing to anasarca, such as controlling hypertension, managing diabetes, and weight management for obesity.
Medication Adherence: Stress the importance of medication compliance, particularly for patients with heart failure and other conditions at risk for anasarca.
Sodium and Fluid Restriction: Educate patients about the significance of limiting sodium and fluid intake, providing practical guidance on dietary modifications.
Self-Care Techniques: Instruct patients on self-care measures for managing edema, such as leg elevation when sitting or lying down and gentle exercises to promote circulation.
Compression Stockings Education: For appropriate patients, educate on the benefits and proper use of compression stockings to reduce swelling and improve circulation.
Trigger Identification: For patients with a history of anasarca, help them identify and avoid triggers that exacerbate their condition, such as excessive salt intake or specific allergens.

Enhancing Healthcare Team Outcomes in Anasarca Management

Effective management of anasarca requires a collaborative, interprofessional healthcare team approach due to its diverse underlying causes and systemic effects. Key roles and strategies for enhancing healthcare team outcomes include:

Primary Care Providers: Play a crucial role in early detection of underlying diseases and anasarca. They are often the first point of contact and can identify early signs and symptoms, initiating timely referrals to specialists.
Specialist Collaboration: Cardiologists, hepatologists, nephrologists, and internists are essential for diagnosing and managing the root causes of anasarca, working collaboratively to address complex cases.
Nursing Staff: Inpatient, outpatient, and home health nurses are vital for monitoring patients, administering medications, managing fluid intake and output, providing patient education, and ensuring continuity of care.
Dietitians: Play a key role in nutritional management, particularly in cases of malnutrition or sodium-sensitive fluid retention, developing tailored nutritional plans.
Pharmacists: Ensure safe and effective medication management, including diuretic therapy, monitoring for drug interactions and side effects.
Physical and Occupational Therapists: Assist patients in regaining mobility and adapting lifestyle to manage edema, improving physical function and quality of life.
Respiratory Therapists: Manage respiratory complications, such as pulmonary edema, providing respiratory support and oxygen therapy when needed.

Effective interprofessional communication, shared care plans, and coordinated follow-up are crucial for optimizing anasarca treatment, improving patient outcomes, and enhancing quality of life.

Review Questions

(Note: Review questions are available in the original article link)

References

(Note: References are listed in the original article and should be included here)

Disclosures

(Note: Disclosure statements are listed in the original article and should be included here)